STAINER, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.508
AS - Asia 1.111
EU - Europa 436
SA - Sud America 141
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 62
OC - Oceania 7
Totale 3.351
Nazione #
US - Stati Uniti d'America 1.465
SG - Singapore 598
CN - Cina 260
IT - Italia 132
VN - Vietnam 117
BR - Brasile 114
FI - Finlandia 53
NG - Nigeria 41
FR - Francia 40
DE - Germania 38
IE - Irlanda 33
HK - Hong Kong 32
CA - Canada 28
IN - India 28
SE - Svezia 28
GB - Regno Unito 26
MK - Macedonia 20
BD - Bangladesh 15
NL - Olanda 14
AR - Argentina 12
PL - Polonia 11
PH - Filippine 9
RU - Federazione Russa 9
IQ - Iraq 8
MX - Messico 8
ZA - Sudafrica 8
AU - Australia 6
UA - Ucraina 6
VE - Venezuela 6
JP - Giappone 5
MY - Malesia 5
PK - Pakistan 5
CO - Colombia 4
ID - Indonesia 4
TR - Turchia 4
DZ - Algeria 3
ES - Italia 3
LT - Lituania 3
LV - Lettonia 3
AZ - Azerbaigian 2
CH - Svizzera 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
KY - Cayman, isole 1
KZ - Kazakistan 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 3.265
Città #
Singapore 260
Ashburn 190
San Jose 134
Chandler 104
Shanghai 104
New York 86
The Dalles 79
Beijing 76
Dallas 70
Boardman 60
Council Bluffs 60
Helsinki 53
Milan 48
Santa Clara 43
Los Angeles 42
Benin City 41
Ho Chi Minh City 37
Dublin 33
Hong Kong 31
Hanoi 27
Lawrence 26
Princeton 25
Paris 21
Naples 16
Charlotte 15
São Paulo 13
Atlanta 12
London 12
Buffalo 11
Wilmington 11
Da Nang 9
San Francisco 9
Seattle 9
Skopje 9
Stockholm 9
Assago 8
Boston 8
Brownsville 8
Chicago 7
Cleveland 7
Falkenstein 7
Frankfurt am Main 7
Phoenix 7
Pune 7
Sacramento 7
Warsaw 7
Amsterdam 6
Chennai 6
Mexico City 6
Rio de Janeiro 6
Rome 6
Bitola 5
Brooklyn 5
Dhaka 5
Erbil 5
Eustis 5
Johannesburg 5
Leawood 5
Montreal 5
Orem 5
Philadelphia 5
San Antonio 5
Severn 5
Sydney 5
Ely 4
Greeley 4
Houston 4
Mumbai 4
Toronto 4
Vacaville 4
Yukon 4
Ankara 3
Biên Hòa 3
Buenos Aires 3
Calgary 3
City of London 3
Converse 3
Greeneville 3
Hải Dương 3
Kuala Lumpur 3
Miami 3
Olongapo City 3
Pasadena 3
Prilep 3
Riga 3
San Mateo 3
St Petersburg 3
Vermilion 3
Vũng Tàu 3
Winnipeg 3
Amman 2
Asagayakita 2
Athens 2
Baku 2
Bogotá 2
Bogovinje 2
Bristol 2
Bắc Ninh 2
Canyon Country 2
Caracas 2
Totale 2.065
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 225
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 145
COVID-19 in Immunocompromised Patients: A Systematic Review 113
Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults 104
Cardiovascular Complications in Community-Acquired Pneumonia 101
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 89
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 85
Treatable traits in interstitial lung diseases: a call to action 84
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 82
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma 81
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 81
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 80
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 78
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 78
Early or delayed bronchoscopy in patients admitted to the emergency department for mild-to-moderate hemoptysis? 76
Identifying risk factors and pathogens in postoperative pneumonia after lung surgery for cancer: a retrospective cohort study 75
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 75
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 72
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 66
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 66
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions 66
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 65
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 65
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 64
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 64
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 63
Long-Term Outcomes in Severe Community-Acquired Pneumonia 62
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 62
Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview 60
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 60
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 59
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 59
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 58
Walking the path of treatable traits in interstitial lung diseases 56
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 56
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 54
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 54
Treatable Traits in Systemic Sclerosis 53
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 53
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 52
Diagnostic delay in bronchiectasis: an Italian perspective 51
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 51
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 44
Response to: are there over 200 distinct types of interstitial lung diseases? 42
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 41
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 36
Global Variation in Pneumonia Epidemiology 14
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation 9
Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature 8
Bronchiectasis in Italy: an analysis of the EMBARC registry 8
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study 6
Totale 3.351
Categoria #
all - tutte 21.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022110 0 1 1 2 0 0 1 2 23 44 31 5
2022/2023366 53 12 46 9 40 22 17 30 61 42 27 7
2023/2024437 38 16 66 42 10 75 33 18 18 17 41 63
2024/2025589 11 6 9 14 14 72 45 25 132 118 65 78
2025/20261.511 197 83 78 92 85 66 384 94 92 131 110 99
2026/2027305 216 89 0 0 0 0 0 0 0 0 0 0
Totale 3.351